XOMA Corp (NASDAQ:XOMA)
| 21.46 Delayed Data As of Nov 30 |  +0.13 / +0.62%Today’s Change | 15.68 Today|||52-Week Range 32.09 | +2.93% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $219.1M |
Company Description
XOMA Corp. engages in the discovery and development of therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.
Contact Information
XOMA Corp. 2200 Powell Street Emeryville California 94608 |
Employees
Shareholders
| Other institutional | 39.96% |
| Individual stakeholders | 32.44% |
| Mutual fund holders | 19.07% |
Top Executives
| Thomas Burns | Chief Financial Officer & Senior VP-Finance |
| Juliane Snowden | Investor Relations Contact |
